October 2004 – The CenterWatch Monthly : Volume 11, Issue 10, 2003
How Will Investigator Training Be Standardized?
Despite the absence of a regulation that clearly defines what kind of training a clinical investigator needs, the FDA has begun to review investigator training as part of on-site inspections. Government and market pressure to for clinical investigators to be trained and certified is on the increase. In recent months, the three major certifying bodies AAPP, ACRP and DIA began preliminary talks about the feasibility and desirability of forming a single, separate credentialing body where clinical investigators could seek certification after undergoing training through myriad venues, thereby creating a single standard clinical investigator certification. Ultimately, some would like to see pharmaceutical medicine become a medical specialty in which investigators can become board certified.
Call Centers Broaden Coverage Area
As call centers diversify their services and increasingly focus on retention and away from rescue studies, the niche will become ripe for consolidation and more alliances with larger partners will be formed. Smaller call centers will have to broaden their services just to survive. Thomson CenterWatch estimates that the call center market for patient recruitment has grown 80% in the last three years to $97 million.
Clinical Trials Collaborative Marks New Era for U.K. Research
A new collaborative initiative involving industry, government, academics and charities promises to make the United Kingdom a more attractive base for clinical trials in Europe.
Eye On: Eye Disorder
More than 80 million Americans suffer from potentially blinding eye diseases. CenterWatch has identified a pipeline of 20 drugs in development for eye disorders.
- Month in Review
- In the Pipeline
- Opportunities Underway